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To the Editor
More than half of patients with bipolar 
disorder (BD) also have an additional 
psychiatric diagnosis, one of the most 
difficult to manage being obsessive-
compulsive disorder (OCD) (Amerio 
et al., 2014). Overlapping clinical criteria 
for many diagnoses, in particular mood 
and anxiety disorders, produced by the 
Diagnostic and Statistical Manual of 
Mental Disorders (DSM), might lay 
behind these high prevalence rates.
Although recent studies have 
investigated the co-occurrence of 
anxiety disorder and BD, the topic is 
insufficiently studied especially in chil-
dren and adolescents, and the rela-
tionship between BD and OCD 
remains unclear.
We updated our recent system-
atic review (Amerio et al., 2015) and 
performed a meta-analysis of the evi-
dence from the literature to define 
the prevalence of comorbid 
BD-OCD in children and adoles-
cents (Table 1).
We pooled individual study data 
on the prevalence of OCD in BD 
using DerSimonian–Laird proportion 
method utilizing a random effects 
model with Comprehensive Meta-
analysis Software (Version 3). 
Heterogeneity was assessed with the 
Q statistic for each analysis; publica-
tion bias was assessed using the Begg–
Mazumdar Kendall’s tau and Egger 
bias test. When we encountered pub-
lication bias, we conducted a trim and 
fill adjusted analysis.
We pooled data from 345 adoles-
cents with BD (mean age = 12.7 ± 
2.5 years; 54.7% male; range = 36.3–76.8) 
across four studies to establish a 
pooled prevalence of OCD of 23.2% 
(95% confidence interval [CI] = [11.5%, 
41.3%], Q = 30) (Figure 1). There was 
no significant publication bias (Egger 
intercept = −9.1; Begg = 0.08). These 
results showed higher comorbidity 
rates in youths compared to adults 
(13.56%; 95% CI = [10.4, 16.25], 
n = 4539) (Amerio et al., 2015) and 
need to be interpreted in the context 
of the available literature.
As reported by recent studies 
(Cederlöf et al., 2014), obsessive-com-
pulsive (OC) symptoms in childhood 
and adolescence may be expression of 
vulnerability to BD increasing the risk 
of a later BD diagnosis, and being sug-
gestive of partially shared etiopathoge-
netic mechanisms between these 
severe mental disorders.
OC symptoms would initially coex-
ist with BD symptoms—more often, 
and sometimes exclusively, during 
depressive episodes—even cycling 
together and remitting during manic/
hypomanic episodes (Amerio et al., 
2014). OC symptoms would gradually 
tend to decrease in the adulthood.
The clinical features of comorbid 
BD-OCD patients would explain 
why OCD and BD symptoms 
respond to adequate mood stabilizer 
treatment. Addition of low doses of 
antidepressants could be considered 
only in a minority of comorbid 
patients with persistent OCD while 
strictly monitoring emerging symp-
toms of mania or mixed states 
(Amerio et al., 2014).
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Table 1. Studies that met inclusion/exclusion criteria for systematic review.
References Study design Country Study population
Sample 
size
Diagnosis 
assessment Qualitya
Dilsaver et al. 
(2006)
Case control 
study
United States Pt. (n = 313): BD (n = 115, mean 
age = 14.6 ± 1.5)
115 SCID-CV; 
DSM-IV
18/31
Joshi et al. 
(2010)
Case control 
study
United States OCD Pt. (n = 125, age range = 6–17), 
BD Pt. (n = 82, age range = 6–17)
207 K-SADS-E; 
DSM-III-R
19/31
Shon et al. 
(2014)
Cross-sectional 
study
South Korea Pt. (n = 198): BD (n = 55), MDD 
(n = 143)(age range = 6–18)
55 K-SADS-PL; 
DSM-IV
22/31
Tillman et al. 
(2003)
Case control 
study
United States BD Pt. (n = 93, mean 
age = 10.9 ± 2.6)
93 WASH-U-K-
SADS; DSM-IV
20/31
BD: bipolar disorder; OCD: obsessive-compulsive disorder; MDD: major depressive disorder; Pt.: patients; DSM-IV: Diagnostic and Statistical Manual 
of Mental Disorders–Fourth Edition; DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders–Third Edition, Revised; SCID-CV: Structured Clinical 
Interview for DSM Disorders–Clinical Version; DICA-R: Diagnostic Interview for Children and Adolescents–Revised; K-SADS-E: Kiddie Schedule 
for Affective Disorders and Schizophrenia for School-Age Children–Epidemiologic Version; K-SADS-PL: Kiddie Schedule for Affective Disorders and 
Schizophrenia for School-Age Children–Present and Lifetime Version; WASH-U-K-SADS: Washington University in St. Louis Kiddie Schedule for 
Affective Disorders and Schizophrenia; DAWBA: Development and Well-Being Assessment.
aChecklist for measuring study quality developed by Downs and Black.
Figure 1. Pooled prevalence of OCD in BD patients.
Study name Event rate and 95% CI
Event
rate
Lower
limit
Upper
limit
Dilsaver, S. C. et al. 2006 0.470 0.380 0.561
Tillman, R. et al. 2003 0.247 0.170 0.345
Joshi, G. et al. 2010 0.207 0.133 0.308
Shon, S.H. et al. 2014 0.073 0.028 0.178
0.233 0.116 0.414
-1.00 -0.50 0.00 0.50 1.00
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